RxDoctor Payments Data

Nilo Elizalde

Psychiatric/Mental Health · Livonia, MINPI 1841854635

Payments from drug & device makers

$3,404in general payments, 2019–2025

Across 160 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$515
  • Supernus Pharmaceuticals, Inc.$432
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$408
  • Johnson & Johnson$314
  • AbbVie$313
  • Corium, LLC$285
  • plus $1K from 9 others

What the payments were for

  • Food & beverage$3,35599%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,404 in reported general payments places this provider in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$5,204
Medicare patients
15
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole46$6,281
Methylphenidate ErMethylphenidate Hcl19$3,060
Carbamazepine ErCarbamazepine20$1,606
Quetiapine Fumarate77$1,215
Haloperidol Decanoate30$936
Ziprasidone Hcl15$914
Fluoxetine Hcl32$824
Prazosin Hcl15$760
Carbamazepine12$646
Duloxetine Hcl21$642
Hydroxyzine Hcl34$627
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine41$536
Paroxetine Hcl38$448
Divalproex Sodium ErDivalproex Sodium20$383
Trazodone Hcl53$375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$46$25440 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Livonia

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →